Key result
Serum serotonin concentration is positively associated with bone mineral density and content in postmenopausal women (r = 0.20 to 0.42, p<0.05), but not in premenopausal women or men.
Why the study?
Is fasting serum serotonin associated with bone traits in men and women?
Cross-Sectional (n=648)
Is fasting serum serotonin associated with bone traits in men and women?
Effect estimate: r = 0.20 to 0.42
p-value: p=<0.05
Serum serotonin is positively associated with bone traits in postmenopausal women, suggesting an age- and gender-specific role in bone metabolism.
Should not yet guide clinical bone assessment; leaves open an age- and sex-specific role for serotonin in postmenopausal bone metabolism.
CONTEXT: Serotonin plays a potential role in bone metabolism, but the nature and extent of this relationship is unclear and human studies directly addressing the skeletal effect of circulating serotonin are rare. OBJECTIVE: The study aimed to investigate the associations between serum serotonin and bone traits at multiple skeletal sites in women and men. SUBJECTS AND METHODS: Subjects were part of the CALEX-family study and comprised 235 young women, 121 premenopausal women, 124 postmenopausal women, and 168 men. Body composition was assessed using DXA, as was areal bone mineral density (aBMD) of spine, femur and whole body. In addition, pQCT was used to determine bone properties at tibial midshaft and distal radius. Fasting serum serotonin concentration was assessed using a competitive enzyme-linked immunosorbent assay. RESULTS: Serum serotonin declined with advancing age both in females and males (all p<0.01). Serotonin was negatively correlated with weight, BMI, lean and fat mass in women (r = -0.22 to -0.39, all p<0.001), but positively with height and lean mass in men (all p<0.01). In the premenopausal women, serotonin was negatively correlated with lumbar spine aBMD (r = -0.23, p<0.05) but the statistical significance disappeared after adjustment for weight. Conversely, in postmenopausal women, serotonin was positively correlated with whole body and femur aBMD, as well as with distal radius bone mineral content and volumetric BMD (r = 0.20 to 0.30, all p<0.05), and these associations remained significant after adjustment for weight. In men, no significant associations were found between serotonin and bone traits. CONCLUSION: Serum serotonin is positively associated with bone traits in postmenopausal women, but not in premenopausal women or men. This partially supports the idea of circulating serotonin playing a role in the regulation of bone metabolism, but also indicates the importance of gender and age specific factors.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2014) conducted a cross-sectional in Healthy subjects (n=648). Serum serotonin concentration was evaluated on Correlation between serum serotonin and bone traits (aBMD, BMC, vBMD) (r = 0.20 to 0.42, p=<0.05). Serum serotonin concentration is positively associated with bone mineral density and content in postmenopausal women (r = 0.20 to 0.42, p<0.05), but not in premenopausal women or men.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: